Global Custom Adeno-Associated Virus (AAV) Services Market Growth (Status and Outlook) 2024-2030

Global Custom Adeno-Associated Virus (AAV) Services Market Growth (Status and Outlook) 2024-2030

Custom Adeno-Associated Virus (AAV) services refer to specialized biotechnological offerings that involve the design, production, and optimization of AAV vectors tailored to specific research or therapeutic needs. These services are typically provided by biotech companies or research institutions and are widely used in gene therapy, genetic research, and preclinical studies.

Custom AAV services are crucial for advancing gene therapy research and developing novel therapeutic approaches for genetic disorders. They provide researchers and clinicians with the tools needed to precisely manipulate gene expression in various cell types and tissues, facilitating the development of effective and targeted treatments.

The global Custom Adeno-Associated Virus (AAV) Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Custom Adeno-Associated Virus (AAV) Services Industry Forecast” looks at past sales and reviews total world Custom Adeno-Associated Virus (AAV) Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Custom Adeno-Associated Virus (AAV) Services sales for 2023 through 2029. With Custom Adeno-Associated Virus (AAV) Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Adeno-Associated Virus (AAV) Services industry.

This Insight Report provides a comprehensive analysis of the global Custom Adeno-Associated Virus (AAV) Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Adeno-Associated Virus (AAV) Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Adeno-Associated Virus (AAV) Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Adeno-Associated Virus (AAV) Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Adeno-Associated Virus (AAV) Services.

United States market for Custom Adeno-Associated Virus (AAV) Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Custom Adeno-Associated Virus (AAV) Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Custom Adeno-Associated Virus (AAV) Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Custom Adeno-Associated Virus (AAV) Services players cover Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Custom Adeno-Associated Virus (AAV) Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Adherent Culture
Suspension Culture

Segmentation by Application:
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Adherent Culture
Suspension Culture

Segmentation by Application:
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics（MolMed）
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
Exthera
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver.